139 related articles for article (PubMed ID: 28545571)
1. Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience.
Oluic B; Paunovic I; Loncar Z; Djukic V; Diklic A; Jovanovic M; Garabinovic Z; Slijepcevic N; Rovcanin B; Micic D; Filipovic A; Zivaljevic V
BMC Cancer; 2017 May; 17(1):371. PubMed ID: 28545571
[TBL] [Abstract][Full Text] [Related]
2. Survival and prognosis in Hürthle cell carcinoma of the thyroid gland.
Bhattacharyya N
Arch Otolaryngol Head Neck Surg; 2003 Feb; 129(2):207-10. PubMed ID: 12578450
[TBL] [Abstract][Full Text] [Related]
3. Favorable Outcome of Hurthle Cell Carcinoma of the Thyroid Treated With Total Thyroidectomy, Radioiodine, and Selective Use of External-Beam Radiotherapy.
Zavitsanos P; Amdur RJ; Drew PA; Cusi K; Werning JW; Morris CG
Am J Clin Oncol; 2017 Aug; 40(4):433-437. PubMed ID: 25730603
[TBL] [Abstract][Full Text] [Related]
4. Aggressiveness of therapy and prognosis of patients with Hürthle cell papillary thyroid carcinoma.
Besic N; Hocevar M; Zgajnar J; Petric R; Pilko G
Thyroid; 2006 Jan; 16(1):67-72. PubMed ID: 16487016
[TBL] [Abstract][Full Text] [Related]
5. Hürthle cell carcinoma: a 60-year experience.
Stojadinovic A; Hoos A; Ghossein RA; Urist MJ; Leung DH; Spiro RH; Shah JP; Brennan MF; Singh B; Shaha AR
Ann Surg Oncol; 2002 Mar; 9(2):197-203. PubMed ID: 11888879
[TBL] [Abstract][Full Text] [Related]
6. [Differentiated thyroid carcinoma: survival and prognostic factors].
Sastre Marcos J; Llamazares Iglesias O; Vicente Delgado A; Marco Martínez A; Cánovas Gaillemin B; Orradre Romero JL; Morlan López MÁ; López López J
Endocrinol Nutr; 2011 Apr; 58(4):157-62. PubMed ID: 21419724
[TBL] [Abstract][Full Text] [Related]
7. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart.
Haigh PI; Urbach DR
Surgery; 2005 Dec; 138(6):1152-7; discussion 1157-8. PubMed ID: 16360403
[TBL] [Abstract][Full Text] [Related]
8. Radioactive Iodine Treatment Is Associated with Improved Survival for Patients with Hürthle Cell Carcinoma.
Jillard CL; Youngwirth L; Scheri RP; Roman S; Sosa JA
Thyroid; 2016 Jul; 26(7):959-64. PubMed ID: 27150319
[TBL] [Abstract][Full Text] [Related]
9. Hürthle cell tumors: applying molecular markers to define a new management algorithm.
Maxwell EL; Palme CE; Freeman J
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):54-8. PubMed ID: 16415430
[TBL] [Abstract][Full Text] [Related]
10. Patients with follicular and Hurthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients.
Kuo EJ; Roman SA; Sosa JA
Surgery; 2013 Dec; 154(6):1246-53; discussion 1253-4. PubMed ID: 23993409
[TBL] [Abstract][Full Text] [Related]
11. Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?
Sugino K; Kameyama K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
Ann Surg Oncol; 2013 Sep; 20(9):2944-50. PubMed ID: 23616135
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experience.
Petric R; Gazic B; Besic N
BMC Cancer; 2014 Oct; 14():777. PubMed ID: 25338674
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer.
Benbassat CA; Mechlis-Frish S; Hirsch D
World J Surg; 2006 Jun; 30(6):1088-95. PubMed ID: 16736341
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and survival analysis of Hurthle cell carcinoma: A population-based study.
Humphreys BM; Memeh KO; Funkhouser A; Vaghaiwalla TM
Surgery; 2022 Nov; 172(5):1379-1384. PubMed ID: 36038373
[TBL] [Abstract][Full Text] [Related]
16. Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: a single-institution experience.
Besic N; Schwarzbartl-Pevec A; Vidergar-Kralj B; Crnic T; Gazic B; Marolt Music M
BMC Cancer; 2016 Feb; 16():162. PubMed ID: 26921186
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases.
Ghossein RA; Hiltzik DH; Carlson DL; Patel S; Shaha A; Shah JP; Tuttle RM; Singh B
Cancer; 2006 Apr; 106(8):1669-76. PubMed ID: 16534796
[TBL] [Abstract][Full Text] [Related]
18. Hürthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003.
Mills SC; Haq M; Smellie WJ; Harmer C
Eur J Surg Oncol; 2009 Mar; 35(3):230-4. PubMed ID: 18722077
[TBL] [Abstract][Full Text] [Related]
19. Prognostic indications for Hürthle cell cancer.
Kushchayeva Y; Duh QY; Kebebew E; Clark OH
World J Surg; 2004 Dec; 28(12):1266-70. PubMed ID: 15517492
[TBL] [Abstract][Full Text] [Related]
20. Hurthle cell carcinoma: a population-level analysis of 3311 patients.
Goffredo P; Roman SA; Sosa JA
Cancer; 2013 Feb; 119(3):504-11. PubMed ID: 22893587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
